PATENT CLAIM ANALYSIS

Application Number: 15899675
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "419000"]

Abstract:
The invention relates to the use of compounds of general structure (I) in modulation of the Wnt pathway [Formula should be inserted here] wherein R 1 , R 2 , R 3 , R 4  and R 5  are each, independently, H or an alkyl group; D is selected from the group consisting of H, halogen, alkyl, cycloalkyl, aryl, and dialkylamino, each (other than H and halogen) being optionally substituted; Ar is an aryl or heteroaryl group, optionally substituted; Cy is an aryl, heteroaryl or a saturated ring containing at least one heteroatom, each being optionally substituted; and n is an integer from 1 to 3.

Claim (Index 85):
A method of treating a disease or condition associated with Wnt pathway activity, comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to  claim 67 , wherein the disease or condition is selected from the cancer, pulmonary fibrosis, liver fibrosis, skin fibrosis, renal fibrosis, a degenerative disease, diabetic retinopathy, stem cell retinopathy, rheumatoid arthritis, psoriasis, and myocardial infarction.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.82857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15668260', '14893172', '11990652', '13849826', '14034945']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7573530907969753
- 35 USC 102 Novelty (BERT): 0.5550311114745181
- Combined Prediction Score: 0.7371208928647296
- Mean Citation Score: 362.82729200000006
- Max Citation Score: 498.7928
- Similarity Product: 247.8558020781994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test